(CIAO@TBI) Complement Inhibition: Attacking Overshooting Inflammation @fter traumatic brain injury

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514488-24-02

Enrollment

106

Registered

2024-10-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Brief summary

Therapy Intensity Level Scale

Detailed description

Serious Adverse Events (SAE), Glasgow Outcome Scale Extended

Interventions

DRUGCinryze 500 IU powder and solvent for solution for injection

DRUGSaline Solution Basi 9 mg/ml solution for infusion

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Therapy Intensity Level Scale	—

Secondary

Measure	Time frame
Serious Adverse Events (SAE), Glasgow Outcome Scale Extended	—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026